vs
Side-by-side financial comparison of Idaho Strategic Resources, Inc. (IDR) and Entrada Therapeutics, Inc. (TRDA). Click either name above to swap in a different company.
Entrada Therapeutics, Inc. is the larger business by last-quarter revenue ($20.6M vs $14.6M, roughly 1.4× Idaho Strategic Resources, Inc.). Idaho Strategic Resources, Inc. runs the higher net margin — 64.3% vs -84.4%, a 148.7% gap on every dollar of revenue. On growth, Idaho Strategic Resources, Inc. posted the faster year-over-year revenue change (92.0% vs -65.2%). Idaho Strategic Resources, Inc. produced more free cash flow last quarter ($8.2M vs $-39.7M). Over the past eight quarters, Idaho Strategic Resources, Inc.'s revenue compounded faster (57.2% CAGR vs 6.4%).
Idaho Strategic Resources, Inc.IDREarnings & Financial Report
Idaho Strategic Resources, Inc. is a U.S.-based natural resource company focused on the exploration, development, and production of critical and strategic minerals. Primarily operating in Idaho, it targets rare earth elements, gold, silver, and other high-demand minerals, supplying products to the clean energy, defense, and industrial manufacturing sectors across North America.
Entrada Therapeutics is a clinical-stage biotechnology firm developing transformative intracellular therapies for serious rare diseases and high-unmet-need disorders. Its pipeline covers neuromuscular, metabolic, and central nervous system segments, serving global patients via healthcare partnerships.
IDR vs TRDA — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $14.6M | $20.6M |
| Net Profit | $9.4M | $-17.3M |
| Gross Margin | 68.5% | — |
| Operating Margin | 62.4% | -106.0% |
| Net Margin | 64.3% | -84.4% |
| Revenue YoY | 92.0% | -65.2% |
| Net Profit YoY | 220.6% | -173.8% |
| EPS (diluted) | $0.62 | $-0.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $14.6M | — | ||
| Q3 25 | $11.1M | — | ||
| Q2 25 | $9.5M | — | ||
| Q1 25 | $7.3M | $20.6M | ||
| Q4 24 | $7.6M | $37.4M | ||
| Q3 24 | $6.2M | $19.6M | ||
| Q2 24 | $6.1M | $94.7M | ||
| Q1 24 | $5.9M | $59.1M |
| Q4 25 | $9.4M | — | ||
| Q3 25 | $3.0M | — | ||
| Q2 25 | $2.8M | — | ||
| Q1 25 | $1.6M | $-17.3M | ||
| Q4 24 | $2.9M | $1.1M | ||
| Q3 24 | $1.6M | $-14.0M | ||
| Q2 24 | $2.2M | $55.0M | ||
| Q1 24 | $2.2M | $23.5M |
| Q4 25 | 68.5% | — | ||
| Q3 25 | 63.6% | — | ||
| Q2 25 | 57.8% | — | ||
| Q1 25 | 50.8% | — | ||
| Q4 24 | 53.3% | — | ||
| Q3 24 | 48.7% | — | ||
| Q2 24 | 50.2% | — | ||
| Q1 24 | 48.1% | — |
| Q4 25 | 62.4% | — | ||
| Q3 25 | 23.4% | — | ||
| Q2 25 | 26.6% | — | ||
| Q1 25 | 19.3% | -106.0% | ||
| Q4 24 | 36.2% | -15.7% | ||
| Q3 24 | 23.4% | -110.7% | ||
| Q2 24 | 34.2% | 56.4% | ||
| Q1 24 | 36.3% | 35.7% |
| Q4 25 | 64.3% | — | ||
| Q3 25 | 26.8% | — | ||
| Q2 25 | 29.2% | — | ||
| Q1 25 | 22.1% | -84.4% | ||
| Q4 24 | 38.5% | 3.0% | ||
| Q3 24 | 25.8% | -71.7% | ||
| Q2 24 | 35.2% | 58.1% | ||
| Q1 24 | 36.8% | 39.7% |
| Q4 25 | $0.62 | — | ||
| Q3 25 | $0.20 | — | ||
| Q2 25 | $0.20 | — | ||
| Q1 25 | $0.12 | $-0.42 | ||
| Q4 24 | $0.21 | $-0.20 | ||
| Q3 24 | $0.12 | $-0.35 | ||
| Q2 24 | $0.17 | $1.55 | ||
| Q1 24 | $0.17 | $0.68 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $67.8M |
| Total DebtLower is stronger | $2.3M | — |
| Stockholders' EquityBook value | $108.2M | $417.3M |
| Total Assets | $116.2M | $486.5M |
| Debt / EquityLower = less leverage | 0.02× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $67.8M | ||
| Q4 24 | — | $101.2M | ||
| Q3 24 | — | $78.0M | ||
| Q2 24 | $6.3M | $185.3M | ||
| Q1 24 | $5.3M | $68.4M |
| Q4 25 | $2.3M | — | ||
| Q3 25 | $3.0M | — | ||
| Q2 25 | $3.3M | — | ||
| Q1 25 | $3.7M | — | ||
| Q4 24 | $1.7M | — | ||
| Q3 24 | $2.9M | — | ||
| Q2 24 | $2.7M | — | ||
| Q1 24 | $3.3M | — |
| Q4 25 | $108.2M | — | ||
| Q3 25 | $74.3M | — | ||
| Q2 25 | $49.3M | — | ||
| Q1 25 | $39.8M | $417.3M | ||
| Q4 24 | $37.7M | $428.7M | ||
| Q3 24 | $33.1M | $422.4M | ||
| Q2 24 | $25.4M | $429.9M | ||
| Q1 24 | $21.6M | $269.4M |
| Q4 25 | $116.2M | — | ||
| Q3 25 | $83.1M | — | ||
| Q2 25 | $57.7M | — | ||
| Q1 25 | $48.1M | $486.5M | ||
| Q4 24 | $44.0M | $526.3M | ||
| Q3 24 | $40.8M | $554.6M | ||
| Q2 24 | $32.2M | $582.0M | ||
| Q1 24 | $28.7M | $510.8M |
| Q4 25 | 0.02× | — | ||
| Q3 25 | 0.04× | — | ||
| Q2 25 | 0.07× | — | ||
| Q1 25 | 0.09× | — | ||
| Q4 24 | 0.05× | — | ||
| Q3 24 | 0.09× | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | 0.15× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $10.7M | $-38.5M |
| Free Cash FlowOCF − Capex | $8.2M | $-39.7M |
| FCF MarginFCF / Revenue | 56.0% | -192.9% |
| Capex IntensityCapex / Revenue | 17.7% | 5.6% |
| Cash ConversionOCF / Net Profit | 1.15× | — |
| TTM Free Cash FlowTrailing 4 quarters | $12.4M | $-58.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $10.7M | — | ||
| Q3 25 | $2.4M | — | ||
| Q2 25 | $3.5M | — | ||
| Q1 25 | $2.4M | $-38.5M | ||
| Q4 24 | $3.2M | $-31.6M | ||
| Q3 24 | $2.5M | $-24.3M | ||
| Q2 24 | $2.6M | $39.8M | ||
| Q1 24 | $2.6M | $-25.5M |
| Q4 25 | $8.2M | — | ||
| Q3 25 | $709.8K | — | ||
| Q2 25 | $2.5M | — | ||
| Q1 25 | $1.0M | $-39.7M | ||
| Q4 24 | $2.1M | $-32.2M | ||
| Q3 24 | $1.9M | $-24.9M | ||
| Q2 24 | $2.4M | $38.8M | ||
| Q1 24 | $2.3M | $-26.4M |
| Q4 25 | 56.0% | — | ||
| Q3 25 | 6.4% | — | ||
| Q2 25 | 26.5% | — | ||
| Q1 25 | 13.8% | -192.9% | ||
| Q4 24 | 28.0% | -86.2% | ||
| Q3 24 | 30.4% | -127.3% | ||
| Q2 24 | 38.7% | 41.0% | ||
| Q1 24 | 38.3% | -44.6% |
| Q4 25 | 17.7% | — | ||
| Q3 25 | 15.3% | — | ||
| Q2 25 | 10.8% | — | ||
| Q1 25 | 19.4% | 5.6% | ||
| Q4 24 | 13.6% | 1.7% | ||
| Q3 24 | 9.8% | 3.3% | ||
| Q2 24 | 4.3% | 1.1% | ||
| Q1 24 | 5.5% | 1.4% |
| Q4 25 | 1.15× | — | ||
| Q3 25 | 0.81× | — | ||
| Q2 25 | 1.28× | — | ||
| Q1 25 | 1.50× | — | ||
| Q4 24 | 1.08× | -27.94× | ||
| Q3 24 | 1.56× | — | ||
| Q2 24 | 1.22× | 0.72× | ||
| Q1 24 | 1.19× | -1.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
